Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Welireg Plus Lenvima

Pharmaceutical Executive Daily: FDA Approves Welireg Plus Lenvima

Published 1 month, 3 weeks ago
Description
FDA approves Merck and Eisai's Welireg-Lenvima combination for advanced kidney cancer, a platform-deal roundup covers Novo Nordisk, Genentech, and Roche's tie-ups with Nanexa, Earendil Labs, and Atavistik Bio, and Ron Lanton examines the fight to regulate pharmacy benefit managers.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us